These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3343376)

  • 1. Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.
    Blomjous CE; Schipper NW; Baak JP; van Galen EM; de Voogt HJ; Meyer CJ
    J Clin Pathol; 1988 Jan; 41(1):21-5. PubMed ID: 3343376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids.
    Chin JL; Huben RP; Nava E; Rustum YM; Greco JM; Pontes JE; Frankfurt OS
    Cancer; 1985 Oct; 56(7):1677-81. PubMed ID: 4027899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
    Xue J
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma.
    Blomjous EC; Schipper NW; Baak JP; Vos W; De Voogt HJ; Meijer CJ
    Am J Clin Pathol; 1989 Mar; 91(3):243-8. PubMed ID: 2923091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of bladder carcinomas by flow DNA analysis.
    Gustafson H; Tribukait B
    Eur Urol; 1985; 11(6):410-7. PubMed ID: 4085533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder.
    Deliveliotis C; Georgoulakis J; Skolarikos A; Trakas N; Varkarakis J; Albanis S; Protogerou B; Bamias A
    Urol Res; 2005 Feb; 33(1):39-43. PubMed ID: 15258707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
    Malmström PU
    Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of cytofluorometry in bladder tumors].
    Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
    Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomorphometric and flow cytometric analysis of bladder transitional cell carcinoma using acridine orange fluorochrome: correlation with histopathology and clinical behavior.
    Yu DS; Hsu CM; Chang SY; Ma CP
    J Formos Med Assoc; 1992 Feb; 91(2):152-8. PubMed ID: 1364210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA profile, recurrence rate and progression of superficial G2 cancer of the urinary bladder].
    Maier G; Heissler HE; Blech M; Schröter W
    Urologe A; 1988 May; 27(3):173-6. PubMed ID: 3407050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analysis of DNA content of deparaffinized nuclei in urinary bladder carcinomas. Comparison of different isolation methods and relation to histological grade and stage.
    Malmström PU; Vasko J; Wester K; Norlén BJ; Busch C
    APMIS; 1989 Sep; 97(9):811-9. PubMed ID: 2506919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
    al-Abadi H; Nagel R
    J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of primary and metastatic bladder cancer.
    Badalament RA; O'Toole RV; Keyhani-Rofagha S; Barkley C; Kenworthy P; Accetta P; Wise H; Perez JF; Drago JR
    J Urol; 1990 May; 143(5):912-5; discussion 915-6. PubMed ID: 2329605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA flow cytometry and 67Ki proliferating index as prognostic factors of early recurrence and progression in G1-G2/Ta-T1 and G3/Ta-T1 transitional cell carcinoma of the bladder.
    Tizzani A; Casetta G; Gontero P; Giammò A; Ghabin H; Demurtas S; Pacchioni D
    Minerva Urol Nefrol; 1997 Sep; 49(3):141-3. PubMed ID: 9396221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
    Sun X
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
    de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
    Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA profile and tumour progression in patients with superficial bladder tumours.
    Gustafson H; Tribukait B; Esposti PL
    Urol Res; 1982 Feb; 10(1):13-8. PubMed ID: 7072022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological characterisation of superficial bladder cancer by bivariate cytokeratin 7/DNA analysis, flow cytometric assessment of MIB- 1, and an immunohistochemical study.
    Leonardi E; Dalla Palma P; Reich A; Caffo O; Luciani L
    Anal Cell Pathol; 2000; 21(1):21-33. PubMed ID: 11254222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.